Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, but concerns about tirzepatide and thyroid nodules have emerged from animal studies showing thyroid C-cell tumors in rodents
This article outlines why terpenes require careful risk assessment as cannabis-based medicines move deeper into regulated pharmaceutical frameworks
Personalized nutrition based on genetic testing, microbiome analysis, and metabolic phenotyping represents a frontier in obesity medicine
The program includes Glucose Forecasting, available to enterprise and select consumer members, which predicts the glucose impact of meals without requiring CGM hardware
The nuclear complexes that form change the expression of estrogen-dependent genes to generate multiple growth-promoting signals both inside and outside the nucleus
Document the anemia findings in the progress note: Ferritin 11, Hb 9.4 consistent with iron deficiency. Train staff to double-check lab availability before submitting claims